BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 5, 2012
View Archived Issues
Wellstat Immuno Therapeutics prepares new polypeptides
Read More
Janssen Pharmaceutica discloses new antifungal agents
Read More
German team patents novel integrin ligands for the diagnosis of cancer
Read More
Secondary analysis of patient risk factors in the ARISTOLE trial for thromboembolic events
Read More
Results of the clinical evaluation of combination therapy for drug resistant melanoma
Read More
A new murine model for the study of acute inflammatory arthritis
Read More
Results of the clinical evaluation of a treatment for refractory chronic cough
Read More
AVEO Oncology and Astellas begin enrollment in tivozanib/paclitaxel combination trial
Read More
Neuren Pharmaceuticals presents novel monoclonal antibodies for cancer
Read More
Merck & Co. discloses novel agents for schizophrenia
Read More
Researchers at Sarepta Therapeutics present new peptide conjugates
Read More
EZN-2208, a pegylated drug conjugate for brain tumors
Read More
Bristol-Myers Squibb synthesizes new agents for HCV infection
Read More
Novel deuterated derivatives of PTZ disclosed by Balance Therapeutics
Read More
Genovax sells GX-301 cancer vaccine to Mediolanum Farmaceutici
Read More
New MMP-13 inhibitors divulged by Abbott Laboratories
Read More
Sunshine Biopharma completes studies of anticancer compound Adva-27a
Read More
Phase I study confirms safety and immunogenicity of HIV vaccine
Read More
FDA removes 32-mg single intravenous dose from ondansetron label
Read More
Primary endpoint met for phase III Northera trial
Read More
Theravance initiates phase II study of TD-9855 in fibromyalgia
Read More
Bayer HealthCare obtains European approval for new long-term contraceptive
Read More
BGP-15 shows promising prophylactic and therapeutic effect in collagen-induced arthritis
Read More
Phase III data presented for posttreatment relapse of MS
Read More
The development of a murine model to investigate common pediatric soft tissue sarcomas
Read More
Astellas' NDA for tacrolimus extended-release capsules accepted for review by FDA
Read More
uniQure and Benitec Biopharma enter cross-licensing agreement
Read More